Name (Synonyms) | Correlation | |
---|---|---|
drug1637 | Non-interventional study Wiki | 1.00 |
drug2747 | autologous adipose-derived stem cells Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0001871 | Abnormality of blood and blood-forming tissues HPO | 1.00 |
There is one clinical trial.
This is an observational prospective cohort study to evaluate the clinical course and outcomes of COVID-19 and the underlying disease in patients with hematologic disease (malignant or non-malignant).
Description: Rate of death from any cause
Measure: 30-day all-cause mortality Time: 30 dayDescription: Rate of COVID-19 complications
Measure: COVID-19 complications Time: 30 dayDescription: Rate of ICU admission
Measure: ICU admission Time: 30 dayDescription: Rate of mechanical ventilation / O2 requirement
Measure: Mechanical ventilation / O2 requirement Time: 30 dayDescription: Rate of relapse or progression of hematologic disease
Measure: Relapse or progression of hematologic disease Time: 30 day, 90 day and 180 dayDescription: Number of patients alive
Measure: Overall survival Time: 30 day, 90 day and 180 dayDescription: Putative risk factors for the severity and lethality of COVID-19
Measure: Risk factors Time: 30 day, 90 day and 180 day